Skip to main content
. 2018 Feb 6;13(2):e0192464. doi: 10.1371/journal.pone.0192464

Fig 2. Forest plots of hazard ratios (HRs).

Fig 2

Progression-free survival (PFS) comparing PI3K/AKT/mTOR inhibitors with the control arm. A random-effects model was used.